- About the Library
- Harvard Links
- Digital Resources
- Digital Exhibits
(KU Leuven) Achalasia is a rare disease -- it affects one in 100,000 people -- characterized by a loss of nerve cells in the esophageal wall. While its cause remains unknown, a new study by a team of researchers at KU Leuven in Belgium, the University of Bonn in Germany and other European institutions confirms for the first time that achalasia is autoimmune in origin. The study, published on July 6 in Nature Genetics, is an important step towards unraveling the mysterious disease.
(University of Manchester) A groundbreaking new book that brings together two of the major disciplines behind 'Jurassic Park' is aiming to raise the profile of insect fossils through stunning photographs and unique illustrations.
(University of Adelaide) There's some good news for parents of preterm babies -- latest research from the University of Adelaide shows that by the time they become teenagers, the brains of many preterm children can perform almost as well as those born at term.
(European Molecular Biology Organization) With 30 days to go and almost 2,500 registered participants, the final preparations for the FEBS-EMBO 2014 Conference are well underway. The event, a joint venture between the Federation of European Biochemical Societies, EMBO, and the French Society for Biochemistry and Molecular Biology, will take place from Saturday, Aug. 30, to Thursday, Sept. 4, at the Palais des Congrès in Paris, France.
(23andMe Inc.) 23andMe, the leading personal genetics company, has received from the National Institutes of Health a grant totaling $1,367,504 for a two-year project to support the further development of 23andMe's web-based database and research engine for genetic discovery.
(University of Kent) New research from scientists at the University of Kent has shown for the first time how the structures inside cells are regulated -- a breakthrough that could have a major impact on cancer therapy development.
(University of Maryland School of Medicine) The University of Maryland Schools of Dentistry and Medicine jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases. The grant represents a new direction for the research by studying chlamydial and gonorrheal diseases as the outcome of complex interactions between the host genetics, the urogenital polymicrobial microbiome, and the pathogen's unique genetics.
(Aarhus University) With a new method, researchers use a piece of DNA engineered to bind to metal ions. Using this 'control stick,' they direct another piece of DNA to a metal binding site on the protein.
(Virginia Tech) People with a BRCA1 gene mutation are at much higher risk for breast cancer, but no treatments exist to specifically target this problem. Researchers will use structural biology tools to better understand this difficult-to-treat hereditary cancer.
(University of Cambridge) New research shows that the whip-like appendages on many types of cells are able to synchronize their movements solely through interactions with the fluid that surrounds them.
(University of California - San Francisco) A new study from UC San Francisco is the first to show that while the impact of life's stressors accumulate overtime and accelerate cellular aging, these negative effects may be reduced by maintaining a healthy diet, exercising and sleeping well.
(King's College London) Two beneficial variants of a gene controlling red blood cell development have spread from Africa into nearly all human populations across the globe, according to a new study led by King's College London. The international team studied the genomes of world populations to look for the origin of changes in a key regulator gene which stimulate fetal hemoglobin production into adulthood.
(American Society for Microbiology) About 100 drugs already approved by the US Food and Drug Administration for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, brucellosis, and Mediterranean spotted fever. The findings, published in mBio, the online open-access journal of the American Society for Microbiology, demonstrate a new way of identifying non-antibiotic drugs that could one day help curb bacterial infections.
- Space sex gecko experiment is safe – for now
- Mysterious esophagus disease is autoimmune after all
- Unique images bring fossil insects back to life
- Preterm children's brains can catch up years later
- Counting down to FEBS-EMBO 2014 in Paris, France
- 23andMe scientists receive approximately $1.4 million in funding from National Institutes of Health
- Researchers uncover secrets of internal cell fine-tuning
- University of Maryland Schools of Dentistry and Medicine receive NIH grant
- New method provides researchers with efficient tool for tagging proteins
- Scientists to study hereditary breast cancer to find BRCA1 treatment